Viewing nowCombinationTwinsin Tablet 40/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bionex Co., Ltd.

MFDS item code 201606344 · Approved 2016.10.31 · Insurance code 643104220
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with Amlodipine or Telmisartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with an individual component as described below, switching directly to this medicine may be considered. - 40/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5mg. - 40/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. For patients taking telmisartan and amlodipine concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients for whom this medicine should be administered with caution’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus, especially when taken during the second and third trimesters of pregnancy, and should not be used by pregnant women or women who may become pregnant. Individuals who are allergic to the components of this medicine or have specific health conditions such as certain heart diseases, liver dysfunction, hypotension, or unstable heart failure after acute myocardial infarction should not take this medication. Patients with liver or kidney problems, the elderly, and those with heart valve diseases require special caution when taking this medication and should use it carefully under the guidance of a physician. Dizziness or swelling may occur during use, so if these symptoms persist or worsen, medical consultation is advised. Interaction with other medications is possible, so patients taking other drugs must inform their doctor or pharmacist, especially when taking specific heart drugs, diuretics, lithium, or warfarin. Pregnant or breastfeeding women should not use this medication, and if pregnancy is planned or confirmed, they should stop taking it immediately and consult a healthcare professional. This medication is not recommended for children under 18 years of age due to insufficient evidence of safety and efficacy. Elderly patients may require dosage adjustments and should be cautious as they may exhibit more sensitive reactions when using this medication. In case of overdose, symptoms such as hypotension, cardiac arrhythmia, dizziness, or acute renal failure may appear, so care must be taken not to exceed the recommended dose, and if abnormal symptoms occur, medical assistance must be sought immediately. This medication should be stored out of reach of children, should not be transferred to other containers, and should ideally be taken immediately after opening. Dizziness or drowsiness may occur while driving or operating machinery, so caution is necessary.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in containers that block light. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius, avoiding places that are too hot or too cold.
A double convex oval tablet that is white to light yellow and pale blue.
30 tablets/box [10 tablets/PTP × 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bionex Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.